Revumenib (SNDX-5613)

Vendor: Abmole

Type: Molecular

SKU: M13387

$379.50 USD
Shipping calculated at checkout.

Documents

Coa

Available in stock (500)

  • Customs clearance fees may apply
  • Worldwide shipping available.
For research use only — not intended for clinical or diagnostic purposes.

Product Overview

Bioactivity
Revumenib (SNDX-5613) is a first-in-class, effective and selective Menin-MLL binding inhibitor with Ki of 0.15 nM. Revumenib (SNDX-5613) can be used to study MLL gene rearrangement in acute leukemia, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).
Casnumber
2169919-21-3
Formula
C32H47FN6O4S
Mw
630.82
Psmiles
CCN(C(C)C)C(=O)C1=C(OC2=CN=CN=C2N3CC4(CCN(CC4)CC5CCC(CC5)N[S](=O)(=O)CC)C3)C=CC(=C1)F
Purity
>99%
Solubility
DMSO ≥ 20 mg/mL
Target synonyms
SNDX5613
Revumenib (SNDX-5613)

Revumenib (SNDX-5613)

$379.50 USD